Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)
Clinical trial NCT02759601 · UNKNOWN
Trial details
- NCT number
- NCT02759601
- Sponsor
- Queen Mary University of London
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2018-12-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.